News Search

“For those who were recently infected or boosted, the cross-protection against JN.1 should be decent,” said David Ho, a virologist at Columbia who led the research on JN.1 and Covid vaccines.

“It would suggest that those people who were not recently boosted probably would not be well-protected against JN.1," said David Ho, a professor of microbiology and immunology at Columbia University.